These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23751563)

  • 41. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.
    Sinha MK; Gaze DC; Tippins JR; Collinson PO; Kaski JC
    Circulation; 2003 May; 107(19):2403-5. PubMed ID: 12742986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure.
    Ellidag HY; Eren E; Yılmaz N; Cekin Y
    Redox Rep; 2014 May; 19(3):118-23. PubMed ID: 24620936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ischemia-modified albumin as an oxidative stress marker in preeclampsia.
    Ustün Y; Engin-Ustün Y; Oztürk O; Alanbay I; Yaman H
    J Matern Fetal Neonatal Med; 2011 Mar; 24(3):418-21. PubMed ID: 20617896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic and prognostic value of Ischemia-modified albumin in patients with Crimean-Congo hemorrhagic fever.
    Mentese A; Koksal I; Sumer AU; Arslan M; Karahan SC; Yılmaz G
    J Med Virol; 2013 Apr; 85(4):684-8. PubMed ID: 23364834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ischemia-modified albumin in relation to exercise stress testing.
    Sbarouni E; Georgiadou P; Theodorakis GN; Kremastinos DT
    J Am Coll Cardiol; 2006 Dec; 48(12):2482-4. PubMed ID: 17174185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease.
    Laske C; Leyhe T; Stransky E; Eschweiler GW; Bueltmann A; Langer H; Stellos K; Gawaz M
    J Psychiatr Res; 2008 Jul; 42(9):746-51. PubMed ID: 17854831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis.
    Albarello K; dos Santos GA; Bochi GV; Sangoi MB; Almeida TC; Paz da Silva JE; Garcia SC; Moresco RN
    Clin Biochem; 2012 Apr; 45(6):450-4. PubMed ID: 22342921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease.
    Greilberger J; Koidl C; Greilberger M; Lamprecht M; Schroecksnadel K; Leblhuber F; Fuchs D; Oettl K
    Free Radic Res; 2008 Jul; 42(7):633-8. PubMed ID: 18654878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof].
    Liu XQ; Liu XQ; Jiang P; Huang H; Yan Y
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2246-9. PubMed ID: 19087670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress?
    Lim JS; Yang JH; Chun BY; Kam S; Jacobs DR; Lee DH
    Free Radic Biol Med; 2004 Oct; 37(7):1018-23. PubMed ID: 15336318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ischemia-modified albumin predicts mortality in ESRD.
    Sharma R; Gaze DC; Pellerin D; Mehta RL; Gregson H; Streather CP; Collinson PO; Brecker SJ
    Am J Kidney Dis; 2006 Mar; 47(3):493-502. PubMed ID: 16490629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ischemia-modified albumin levels in cerebrovascular accidents.
    Gunduz A; Turedi S; Mentese A; Altunayoglu V; Turan I; Karahan SC; Topbas M; Aydin M; Eraydin I; Akcan B
    Am J Emerg Med; 2008 Oct; 26(8):874-8. PubMed ID: 18926343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study.
    Hansson O; Stomrud E; Vanmechelen E; Östling S; Gustafson DR; Zetterberg H; Blennow K; Skoog I
    J Alzheimers Dis; 2012; 28(1):231-8. PubMed ID: 21955816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease.
    Korolainen MA; Pirttilä T
    Acta Neurol Scand; 2009 Jan; 119(1):32-8. PubMed ID: 18547271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbon dioxide pneumoperitoneum induces systemic oxidative stress: a clinical study.
    Aran T; Unsal MA; Guven S; Kart C; Cetin EC; Alver A
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):80-3. PubMed ID: 22142814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia.
    Duarte MM; Rocha JB; Moresco RN; Duarte T; Da Cruz IB; Loro VL; Schetinger MR
    Clin Biochem; 2009 May; 42(7-8):666-71. PubMed ID: 19318029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.
    Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T
    J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum clusterin levels are not increased in presymptomatic Alzheimer's disease.
    IJsselstijn L; Dekker LJ; Koudstaal PJ; Hofman A; Sillevis Smitt PA; Breteler MM; Luider TM
    J Proteome Res; 2011 Apr; 10(4):2006-10. PubMed ID: 21280673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
    Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
    Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.